Dr. Mix is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
750 E Adams St
Department of Radiation Oncology
Syracuse, NY 13210Phone+1 315-464-5276
Education & Training
University at BuffaloResidency, Radiation Oncology, 2012 - 2016
St Joseph's HealthInternship, Transitional Year, 2011 - 2012
SUNY Upstate Medical UniversityClass of 2011
Certifications & Licensure
NY State Medical License 2016 - 2025- American Board of Radiology Radiation Oncology
Clinical Trials
- Atezolizumab Immunotherapy With or Without Tiragolumab for Patients With Unresectable Stage III NSCLC Start of enrollment: 2023 Dec 07
Roles: Contact
Publications & Presentations
PubMed
- Quality of life outcomes in patients participating in the CALGB 30610 trial (CALGB 70702): Alliance.Apar K Ganti, Briant Fruth, Andreas Rimner, Saiama Waqar, Michael D Mix
Cancer. 2025-01-01 - Implications of the partial volume effect correction on the spatial quantification of hypoxia based on [F]FMISO PET/CT data.Athanasios Kafkaletos, Ilias Sachpazidis, Michael Mix, Montserrat Carles, Henning Schäfer
Physica Medica. 2024-12-01 - Repeat GammaTile Brachytherapy in the Long-Term Management of Recurrent High-Grade Glioma: A Case Report.Jeff F Zhang, Michael D Mix, Anna Shapiro, Harish Babu
Cureus. 2024-12-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
